Exome Asset Management
Fund of fundsNew York · Growth–Late Stage
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
HQs:China×1
Investments · 1 tracked
founders shown can be your intro pathGracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases.
BiotechHealthtechMedical DevicesSuzhou, CN
William Wei Cao
Co-investorsLAVLilly Asia VenturesOrbiMedJanus Henderson InvestorsPivotal Life SciencesRA Capital+2 more
Frequently asked questions
- What stage does Exome Asset Management invest at?
- Exome Asset Management invests at the Growth, Late Stage stages.
- What sectors does Exome Asset Management focus on?
- Exome Asset Management focuses on Healthtech.
- Where is Exome Asset Management located?
- Exome Asset Management is headquartered in New York, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Balderton Capital is a European venture capital firm that backs technology startups.